What is it about?

High dose of allopurinol leads ESA resistance in patients with advanced CKD (G5).

Featured Image

Read the Original

This page is a summary of: The Association between High-Dose Allopurinol and Erythropoietin Hyporesponsiveness in Advanced Chronic Kidney Disease: JOINT-KD Study, February 2024, Karger Publishers,
DOI: 10.1159/000535874.
You can read the full text:

Read

Contributors

The following have contributed to this page